Free Trial

Analysts Set Tempus AI, Inc. (NASDAQ:TEM) Price Target at $45.56

Tempus AI logo with Medical background

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) has been assigned an average rating of "Moderate Buy" from the ten brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $45.56.

Several research firms recently commented on TEM. JPMorgan Chase & Co. lifted their target price on shares of Tempus AI from $42.00 to $47.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 7th. Needham & Company LLC reissued a "buy" rating and issued a $47.00 price objective on shares of Tempus AI in a research note on Wednesday, August 7th. Piper Sandler initiated coverage on Tempus AI in a report on Monday, August 12th. They issued a "neutral" rating and a $40.00 price objective for the company. Stifel Nicolaus assumed coverage on Tempus AI in a report on Tuesday, July 9th. They set a "buy" rating and a $45.00 target price on the stock. Finally, Longbow Research assumed coverage on Tempus AI in a research note on Tuesday, July 9th. They issued a "buy" rating and a $48.00 price target for the company.

View Our Latest Stock Analysis on Tempus AI

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of TEM. Sandia Investment Management LP bought a new stake in shares of Tempus AI during the second quarter worth about $136,000. Northwestern University acquired a new position in Tempus AI during the 2nd quarter valued at about $491,000. Squarepoint Ops LLC bought a new stake in Tempus AI during the 2nd quarter worth approximately $633,000. WINTON GROUP Ltd purchased a new stake in shares of Tempus AI in the second quarter worth approximately $634,000. Finally, Scientech Research LLC purchased a new stake in shares of Tempus AI in the second quarter worth approximately $756,000.


Tempus AI Stock Down 13.5 %

Shares of NASDAQ TEM traded down $9.24 during mid-day trading on Wednesday, hitting $59.23. 1,226,414 shares of the stock traded hands, compared to its average volume of 1,245,942. Tempus AI has a twelve month low of $22.89 and a twelve month high of $77.00. The firm's 50 day simple moving average is $41.71.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing analysts' consensus estimates of ($4.41) by ($2.36). The firm had revenue of $165.97 million during the quarter, compared to analysts' expectations of $159.10 million. On average, research analysts anticipate that Tempus AI will post -6.51 earnings per share for the current fiscal year.

Tempus AI Company Profile

(Get Free Report

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

See Also

Analyst Recommendations for Tempus AI (NASDAQ:TEM)

Should you invest $1,000 in Tempus AI right now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Tesla Stock: Profits vs. Price—Is It Time to Sell?

Tesla Stock: Profits vs. Price—Is It Time to Sell?

Find out why some believe it might be time to move on from Tesla stock, while others still see potential in its long-term growth.

Related Videos

Top Stocks to Buy, Sell, and Hold Right Now
Tesla Stock Dip: A Buyer’s Alert
Opportunities Arise as Stock Market Rotates from Big Tech

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines